Lescoat Alain, Zimmermann François, Murray Charles D, Khanna Dinesh, Hughes Michael, McMahan Zsuzsanna H
Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.
EHESP, Irset (Institut de Recherche en Santé, Univ Rennes, CHU Rennes, Inserm, Environnement et Travail) - UMR_S 1085, Rennes, France.
Rheumatology (Oxford). 2025 Apr 1;64(4):1609-1626. doi: 10.1093/rheumatology/keae691.
This scoping review sought to summarize the current knowledge on the epidemiology, pathogenesis and clinical presentation of, and the investigations that may help characterize faecal incontinence (FI) in patients with SSc.
The planned scoping review was based on the methodological framework proposed by Arksey and O'Malley. Two databases were screened: PubMed (Medline), (Web of Science), and data extraction was performed using a predefined template.
A total of 454 abstracts were screened and 61 articles were finally included, comprising 32 original articles. The prevalence of FI was 0.4% to 77% in original articles that did not use FI among the mandatory inclusion criteria. Internal anal sphincter was reported as more impacted than external sphincter and vasculopathy of arterioles and extracellular matrix deposition with fibrous replacement of the internal sphincter were the key underlaying pathogenic events. The most represented patient-reported outcome in original articles was the Wexner FI score (22% of original articles) followed by the UCLA SCTC-GIT 2.0 (16% of original articles). Although there is no validated diagnostic approach for FI in SSc, 47% of original articles used anorectal manometry to assess rectal physiology in SSc patients. Conservative measures to treat either liquid or hard stool including anti-diarrhoeal medications and dietary adjustments were the first step of proposed FI management in included narrative reviews and guidelines.
This is the first scoping review exploring FI in SSc. We propose a new research agenda which may help improve treatment strategies and foster research focusing on a neglected manifestation of SSc.
本范围综述旨在总结目前关于系统性硬化症(SSc)患者粪便失禁(FI)的流行病学、发病机制、临床表现以及有助于其特征化的相关检查的知识。
计划中的范围综述基于Arksey和O'Malley提出的方法框架。筛选了两个数据库:PubMed(Medline)、(科学网),并使用预定义模板进行数据提取。
共筛选了454篇摘要,最终纳入61篇文章,其中包括32篇原创文章。在未将FI纳入强制纳入标准的原创文章中,FI的患病率为0.4%至77%。据报道,内括约肌比外括约肌受影响更大,小动脉血管病变和细胞外基质沉积伴内括约肌纤维替代是关键的潜在致病事件。原创文章中最常提及的患者报告结局是Wexner FI评分(占原创文章的22%),其次是加州大学洛杉矶分校SCTC - GIT 2.0(占原创文章的16%)。尽管尚无针对SSc患者FI的有效诊断方法,但47%的原创文章使用肛门直肠测压法评估SSc患者的直肠生理功能。在纳入的叙述性综述和指南中,针对稀便或硬便的保守治疗措施,包括止泻药物和饮食调整,是拟议的FI管理的第一步。
这是首次探索SSc患者FI的范围综述。我们提出了一个新的研究议程,这可能有助于改进治疗策略,并促进针对SSc一种被忽视表现的研究。